Defilade Capital Management, L.P. 13F holdings, Q2 2026
Holdings as of June 30, 2026 · filings on SEC EDGAR · this is the latest filing on record
Defilade Capital Management, L.P. disclosed 39 US equity positions worth $746.9m in its Q2 2026 13F filing. The largest position was LLY at 6.3% of the reported book, followed by PFE and VEEV. Against the Q1 2026 filing, it opened 20 new positions, added to 7 and reduced 10 among the top 39 holdings.
What did Defilade Capital Management, L.P. own in Q2 2026? Top 39 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q1 2026 |
|---|---|---|---|---|---|---|---|
| 1 | LLY ELI LILLY & CO | Healthcare | 6.3% | $46.9m | 39,086 | 89% | added |
| 2 | PFE PFIZER INC | Healthcare | 5.7% | $42.7m | 1,771,743 | 21% | added |
| 3 | VEEV VEEVA SYS INC | Healthcare | 5.6% | $42.0m | 236,709 | – | new |
| 4 | BMRN BIOMARIN PHARMACEUTICAL INC | Healthcare | 5.2% | $39.0m | 682,005 | – | new |
| 5 | PTCT PTC THERAPEUTICS INC | Healthcare | 4.7% | $35.4m | 433,699 | 15% | added |
| 6 | BAX BAXTER INTL INC | Healthcare | 4.2% | $31.1m | 1,459,380 | – | new |
| 7 | INSM INSMED INC | Healthcare | 4.0% | $30.0m | 281,838 | 45% | added |
| 8 | ZBH ZIMMER BIOMET HOLDINGS INC | Healthcare | 3.7% | $27.3m | 317,426 | -45% | reduced |
| 9 | PODD INSULET CORP | Healthcare | 3.6% | $26.9m | 176,932 | – | new |
| 10 | TMO THERMO FISHER SCIENTIFIC INC | Healthcare | 3.5% | $26.0m | 51,934 | – | new |
| 11 | ABT ABBOTT LABORATORIES | Healthcare | 3.5% | $25.9m | 285,778 | – | new |
| 12 | ASND ASCENDIS PHARMA A/S | Healthcare | 3.4% | $25.3m | 94,843 | – | new |
| 13 | SOLV SOLVENTUM CORP | Healthcare | 3.3% | $24.4m | 316,454 | – | new |
| 14 | MDT MEDTRONIC PLC | Healthcare | 3.2% | $23.7m | 303,301 | – | new |
| 15 | ELAN ELANCO ANIMAL HEALTH INC | Healthcare | 2.8% | $21.3m | 864,080 | -7% | reduced |
| 16 | AGIO AGIOS PHARMACEUTICALS INC | Healthcare | 2.7% | $20.3m | 546,848 | – | new |
| 17 | NVST ENVISTA HOLDINGS CORPORATION | Healthcare | 2.6% | $19.1m | 726,108 | – | new |
| 18 | RVMD REVOLUTION MEDICINES INC | Healthcare | 2.1% | $15.5m | 82,827 | -74% | reduced |
| 19 | ICUI ICU MED INC | Healthcare | 2.1% | $15.5m | 105,700 | -58% | reduced |
| 20 | COGT COGENT BIOSCIENCES INC | Healthcare | 2.0% | $15.2m | 393,441 | 12% | added |
| 21 | LNTH LANTHEUS HLDGS INC | Healthcare | 2.0% | $14.7m | 132,662 | -47% | reduced |
| 22 | OCUL OCULAR THERAPEUTIX INC | Healthcare | 2.0% | $14.6m | 1,490,286 | 0% | held |
| 23 | ELDN ELEDON PHARMACEUTICALS INC | 1.9% | $13.9m | 3,525,338 | -1% | reduced | |
| 24 | TYRA TYRA BIOSCIENCES INC | Healthcare | 1.6% | $12.0m | 376,870 | – | new |
| 25 | OLMA OLEMA PHARMACEUTICALS INC | Healthcare | 1.5% | $11.6m | 924,758 | -39% | reduced |
| 26 | ORIC ORIC PHARMACEUTICALS INC | Healthcare | 1.5% | $11.3m | 1,047,690 | 24% | added |
| 27 | LRMR LARIMAR THERAPEUTICS INC | Healthcare | 1.5% | $11.2m | 3,670,135 | – | new |
| 28 | GMED GLOBUS MED INC | Healthcare | 1.5% | $11.0m | 139,637 | -61% | reduced |
| 29 | ENOV ENOVIS CORPORATION | Healthcare | 1.5% | $11.0m | 531,945 | – | new |
| 30 | EVMN EVOMMUNE INC | 1.4% | $10.5m | 793,145 | 17% | added | |
| 31 | TFX TELEFLEX INCORPORATED | Healthcare | 1.4% | $10.2m | 80,118 | – | new |
| 32 | DNLI DENALI THERAPEUTICS INC | Healthcare | 1.3% | $10.1m | 391,866 | -71% | reduced |
| 33 | GKOS GLAUKOS CORP | Healthcare | 1.2% | $9.3m | 66,519 | – | new |
| 34 | STAA STAAR SURGICAL CO | Healthcare | 1.2% | $9.2m | 322,126 | – | new |
| 35 | PACS PACS GROUP INC | Healthcare | 1.2% | $9.2m | 215,675 | -64% | reduced |
| 36 | CRNXGBP CRINETICS PHARMACEUTICALS IN | 1.2% | $9.0m | 239,440 | – | new | |
| 37 | LIVN LIVANOVA PLC | Healthcare | 1.2% | $8.8m | 107,373 | – | new |
| 38 | BDTX BLACK DIAMOND THERAPEUTICS I | 0.4% | $3.1m | 1,674,999 | – | new | |
| 39 | MREO MEREO BIOPHARMA GROUP PLC | Healthcare | 0.3% | $2.4m | 7,558,756 | 0% | held |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.